Bharat Biotech Covid vaccine can be for back-up when cases surge: AIIMS director
Dr Randeep Guleria, the chief of Delhi s All-India Institute of Medical Sciences
(ANI)
Guleria said that Bharat Biotech s vaccine can be used when we re not sure how efficacious the Serum Institute vaccine is going to be Initially, Serum Institute s vaccine will be given. Gradually, we ll build on it and by that time Bharat Biotech s Phase III clinical trials data will also be available, he informed
Share Via
Read Full Story
All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Sunday said that the Covid-19 vaccine manufactured by Bharat Biotech will be used as a back-up for now.
Why Covaxin and Covishield are best option for India against Covid-19 pandemic
India s drugs regulator DCGI on Sunday gave final emergency-use approval for two coronavirus vaccines, Covishield and Covaxin. Know why Covaxin and Covishield are the best options for India!
advertisement
UPDATED: January 4, 2021 00:22 IST
India s drugs regulator DCGI on Sunday gave final emergency-use approval for two coronavirus vaccines: Covishield and Covaxin.
India s drugs regulator DCGI on Sunday
AstraZeneca and Oxford University s Covishield is being manufactured by Pune-based Serum Institute of India (SII). Covaxin has been developed by Hyderabad-based Bharat Biotech, Indian Council of Medical Research (ICMR), and National Institute of Virology (NIV). It is being manufactured in Bharat Biotech s BSL-3 (Bio-Safety Level 3) facility.
When, how and where will you get Covid-19 vaccine? All you need to know about registration, tracking
When, how and where will you get Covid-19 vaccine? All you need to know about registration, tracking, more
India s drugs regulator DCGI on Sunday gave final emergency-use approval for two coronavirus vaccines. As the move paves a way for rollouts of at least two Covid-19 vaccines in India in the coming days, here is all you need to know about the vaccination process.
advertisement
UPDATED: January 4, 2021 00:14 IST
Covid-19 vaccines will be offered first to healthcare and other frontline workers. (Illustration by Bandeep Singh)
: Sunday, January 3, 2021, 10:54 PM IST
Oxford, Bharat Biotech s vaccines approved for emergency use; PM hails it as âMade in Indiaâ moment
Representational Image
Your eternal wait for the prick of a needle is over â a prick that may add years to your life and, more important, change your outlook towards it.
Redemption lies for the suffering millions in two vaccines that have been cleared by the drugs regulator for restricted emergency use in the country.
While UK-based Oxford Institute s Covishield has been developed by the Pune-based Serum Institute, Hyderabad-based Bharat Biotech s Covaxin is an outcome of collaboration with the Indian Council of Medical Research. To that extent, both vaccines are home-spun.